GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Atlas Global Brands Inc (XCNQ:ATL) » Definitions » ROE %

Atlas Global Brands (XCNQ:ATL) ROE % : -159.80% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Atlas Global Brands ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Atlas Global Brands's annualized net income for the quarter that ended in Dec. 2023 was C$-20.08 Mil. Atlas Global Brands's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was C$12.56 Mil. Therefore, Atlas Global Brands's annualized ROE % for the quarter that ended in Dec. 2023 was -159.80%.

The historical rank and industry rank for Atlas Global Brands's ROE % or its related term are showing as below:

XCNQ:ATL' s ROE % Range Over the Past 10 Years
Min: -4.92   Med: 0   Max: 0
Current: -4.92

XCNQ:ATL's ROE % is not ranked
in the Drug Manufacturers industry.
Industry Median: 4.13 vs XCNQ:ATL: -4.92

Atlas Global Brands ROE % Historical Data

The historical data trend for Atlas Global Brands's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atlas Global Brands ROE % Chart

Atlas Global Brands Annual Data
Trend
ROE %

Atlas Global Brands Quarterly Data
Dec22 Jun23 Sep23 Dec23
ROE % - 147.45 -69.59 -159.80

Competitive Comparison of Atlas Global Brands's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Atlas Global Brands's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atlas Global Brands's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Atlas Global Brands's ROE % distribution charts can be found below:

* The bar in red indicates where Atlas Global Brands's ROE % falls into.



Atlas Global Brands ROE % Calculation

Atlas Global Brands's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Atlas Global Brands's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-20.076/( (15.016+10.111)/ 2 )
=-20.076/12.5635
=-159.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Atlas Global Brands  (XCNQ:ATL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-20.076/12.5635
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-20.076 / 34.388)*(34.388 / 66.0215)*(66.0215 / 12.5635)
=Net Margin %*Asset Turnover*Equity Multiplier
=-58.38 %*0.5209*5.255
=ROA %*Equity Multiplier
=-30.41 %*5.255
=-159.80 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-20.076/12.5635
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-20.076 / -20.08) * (-20.08 / -9.86) * (-9.86 / 34.388) * (34.388 / 66.0215) * (66.0215 / 12.5635)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9998 * 2.0365 * -28.67 % * 0.5209 * 5.255
=-159.80 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Atlas Global Brands ROE % Related Terms

Thank you for viewing the detailed overview of Atlas Global Brands's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Atlas Global Brands (XCNQ:ATL) Business Description

Traded in Other Exchanges
Address
566 Riverview Drive, Unit 104, Chatham, ON, CAN, N7M 0N2
Website
Atlas Global Brands Inc is a licensed cannabis company operating in Canada and Israel with experience across the cannabis value chain including cultivation, manufacturing, scalability, marketing, distribution, and pharmacy. Atlas currently serves eight countries: Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom.

Atlas Global Brands (XCNQ:ATL) Headlines

No Headlines